Cipla, 500087, CIPLA Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,27,124.34
23.38
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,26,416.60
1.02%
3.89

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.32
7.53
6.58

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.14
10.90
7.39

PAT CAGR (%)

10 Years
5 Years
3 Years

14.46
16.97
23.59

P:E (Median)

8 Years
5 Years
3 Years

30.34
29.97
29.12

P:BV (Average)

8 Years
5 Years
3 Years

3.65
3.98
4.05

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.63
16.27
16.23

Earnings Forecasts:

(Updated: 08-09-2025)

Description 2024 2025 2026 2027
Adj EPS 65.29 62.41 65.2 71.2
P/E Ratio 24.12 25.23 24.15 22.12
Revenue 27145.4 29529.4 31814.8 34500.9
EBITDA 7127.9 7215.43 7514.61 8238.85
Net Income 5272.52 5028.66 5248.91 5726.56
ROA 15.04 12.83 12.04 11.74
P/B Ratio 4.08 3.63 3.25 2.94
ROE 18.21 15.04 13.98 13.96
FCFF 4081.18 3899.41 3855.44 5861.93
FCFF Yield 3.66 3.49 3.45 5.25
Net Debt -7654.88 -10254.1 -12729.9 -15014.5
BVPS 386.24 434 484.67 536.08

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 5,046.17 4,501.05 12.11% 4,797.89 4,036.66 18.86% 4,970.88 4,381.33 13.46% 4,775.03 4,234.44 12.77%
Expenses 3,421.72 3,141.19 8.93% 3,479.18 3,208.77 8.43% 3,309.05 3,025.47 9.37% 3,336.99 3,009.06 10.90%
EBITDA 1,624.45 1,359.86 19.46% 1,318.71 827.89 59.29% 1,661.83 1,355.86 22.57% 1,438.04 1,225.38 17.35%
EBIDTM 32.19% 30.21% 27.49% 20.51% 33.43% 30.95% 30.12% 28.94%
Other Income 271.07 213.52 26.95% 293.37 538.61 -45.53% 188.69 168.98 11.66% 289.14 205.09 40.98%
Interest 5.88 5.07 15.98% 3.49 5.45 -35.96% 3.55 9.06 -60.82% 3.00 6.61 -54.61%
Depreciation 145.69 137.86 5.68% 147.70 136.81 7.96% 142.62 135.02 5.63% 145.71 179.81 -18.96%
PBT 1,743.95 1,430.45 21.92% 1,755.55 1,224.24 43.40% 1,704.35 1,380.76 23.44% 1,578.47 1,244.05 26.88%
Tax 440.82 374.51 17.71% 270.15 242.21 11.54% 266.20 363.00 -26.67% 400.31 328.51 21.86%
PAT 1,303.13 1,055.94 23.41% 1,485.40 982.03 51.26% 1,438.15 1,017.76 41.31% 1,178.16 915.54 28.68%
PATM 25.82% 23.46% 30.96% 24.33% 28.93% 23.23% 24.67% 21.62%
EPS 16.17 13.10 23.44% 18.43 12.18 51.31% 17.84 12.63 41.25% 14.62 11.36 28.70%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 6,957.47 6,693.94 3.94% 6,729.69 6,163.24 9.19% 7,072.97 6,603.81 7.10% 7,051.02 6,678.15 5.58%
Expenses 5,179.33 4,978.14 4.04% 5,192.10 4,847.38 7.11% 5,084.05 4,856.28 4.69% 5,165.43 4,944.40 4.47%
EBITDA 1,778.14 1,715.80 3.63% 1,537.59 1,315.86 16.85% 1,988.92 1,747.53 13.81% 1,885.59 1,733.75 8.76%
EBIDTM 25.56% 25.63% 22.85% 21.35% 28.12% 26.46% 26.74% 25.96%
Other Income 258.56 160.19 61.41% 289.46 249.33 16.10% 221.61 184.63 20.03% 190.61 176.32 8.10%
Interest 14.05 17.95 -21.73% 14.02 17.59 -20.30% 14.64 30.10 -51.36% 15.40 25.80 -40.31%
Depreciation 252.72 246.68 2.45% 308.73 288.34 7.07% 279.80 233.43 19.86% 271.74 290.04 -6.31%
PBT 1,769.93 1,611.36 9.84% 1,504.30 1,259.26 19.46% 1,916.09 1,473.81 30.01% 1,789.06 1,594.23 12.22%
Tax 477.88 435.07 9.84% 279.28 324.86 -14.03% 332.37 405.30 -17.99% 483.04 438.41 10.18%
PAT 1,292.05 1,176.29 9.84% 1,225.02 934.40 31.10% 1,583.72 1,068.51 48.22% 1,306.02 1,155.82 13.00%
PATM 18.57% 17.57% 18.20% 15.16% 22.39% 16.18% 18.52% 17.31%
EPS 16.06 14.58 10.15% 15.13 11.63 30.09% 19.45 13.08 48.70% 16.13 14.01 15.13%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 19,589.97 19,044.85 16,574.34 14,345.34 15,380.82 11,302.71 12,659.15 12,374.01 11,389.90 10,768.49 11,950.69 Net Sales Growth 14.20% 14.91% 15.54% -6.73% 36.08% -10.72% 2.30% 8.64% 5.77% -9.89% Cost Of Goods Sold 5,593.57 4,097.85 3,889.23 3,594.03 4,775.51 3,075.97 3,326.28 3,577.36 3,272.85 3,262.76 3,943.22 Gross Profit 13,996.40 14,947.00 12,685.11 10,751.31 10,605.31 8,226.74 9,332.87 8,796.65 8,117.05 7,505.73 8,007.47 GP Margin 71.45% 78.48% 76.53% 74.95% 68.95% 72.79% 73.72% 71.09% 71.27% 69.70% 67.00% Total Expenditure 13,546.94 13,268.30 12,090.19 11,000.23 11,669.59 8,235.30 9,972.77 9,879.69 9,194.35 9,172.23 9,897.26 Power & Fuel Cost - 290.24 271.66 257.07 247.58 234.58 253.95 264.93 239.01 206.28 207.56 % Of Sales - 1.52% 1.64% 1.79% 1.61% 2.08% 2.01% 2.14% 2.10% 1.92% 1.74% Employee Cost - 3,054.87 2,644.21 2,335.69 2,113.78 1,703.58 1,911.08 1,839.84 1,785.94 1,728.97 1,778.56 % Of Sales - 16.04% 15.95% 16.28% 13.74% 15.07% 15.10% 14.87% 15.68% 16.06% 14.88% Manufacturing Exp. - 3,111.79 2,639.07 2,499.57 2,380.82 1,506.98 2,305.48 2,173.99 2,007.33 1,958.19 1,986.44 % Of Sales - 16.34% 15.92% 17.42% 15.48% 13.33% 18.21% 17.57% 17.62% 18.18% 16.62% General & Admin Exp. - 1,375.32 1,211.77 1,041.29 896.37 714.86 1,001.04 844.40 834.57 774.65 1,022.67 % Of Sales - 7.22% 7.31% 7.26% 5.83% 6.32% 7.91% 6.82% 7.33% 7.19% 8.56% Selling & Distn. Exp. - 864.43 894.54 890.08 907.40 678.66 701.37 804.38 678.09 624.13 583.39 % Of Sales - 4.54% 5.40% 6.20% 5.90% 6.00% 5.54% 6.50% 5.95% 5.80% 4.88% Miscellaneous Exp. - 473.80 539.71 382.50 348.13 320.67 473.57 374.79 376.56 617.25 583.39 % Of Sales - 2.49% 3.26% 2.67% 2.26% 2.84% 3.74% 3.03% 3.31% 5.73% 3.14% EBITDA 6,043.03 5,776.55 4,484.15 3,345.11 3,711.23 3,067.41 2,686.38 2,494.32 2,195.55 1,596.26 2,053.43 EBITDA Margin 30.85% 30.33% 27.05% 23.32% 24.13% 27.14% 21.22% 20.16% 19.28% 14.82% 17.18% Other Income 1,042.27 986.61 1,070.66 464.57 666.70 230.28 913.76 577.52 334.88 129.85 280.30 Interest 15.92 15.11 20.25 22.27 26.93 45.07 36.05 16.97 11.90 39.20 147.07 Depreciation 581.72 573.89 587.59 595.91 546.62 468.62 599.78 562.04 529.61 499.97 442.69 PBT 6,782.32 6,174.16 4,946.97 3,191.50 3,804.38 2,784.00 2,964.31 2,492.83 1,988.92 1,186.94 1,743.97 Tax 1,377.48 1,311.17 1,232.78 861.54 921.80 739.35 646.14 604.42 442.88 212.00 281.67 Tax Rate 20.31% 20.27% 24.92% 28.66% 24.23% 26.56% 21.80% 24.25% 23.17% 17.86% 16.15% PAT 5,404.84 5,157.65 3,714.19 2,144.06 2,882.58 2,044.65 2,318.17 1,888.41 1,468.52 974.94 1,462.30 PAT before Minority Interest 5,404.84 5,157.65 3,714.19 2,144.06 2,882.58 2,044.65 2,318.17 1,888.41 1,468.52 974.94 1,462.30 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 27.59% 27.08% 22.41% 14.95% 18.74% 18.09% 18.31% 15.26% 12.89% 9.05% 12.24% PAT Growth 36.10% 38.86% 73.23% -25.62% 40.98% -11.80% 22.76% 28.59% 50.63% -33.33% EPS 67.06 63.99 46.08 26.60 35.76 25.37 28.76 23.43 18.22 12.10 18.14

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 27,811.15 27,547.62 25,774.09 22,753.12 21,763.34 19,159.59 17,131.99 16,362.41 15,155.71 14,394.29 13,594.89 Net Sales Growth 6.40% 6.88% 13.28% 4.55% 13.59% 11.84% 4.70% 7.96% 5.29% 5.88% Cost Of Goods Sold 8,906.82 8,928.99 8,819.57 8,252.28 8,495.60 7,351.89 5,991.42 5,784.49 5,438.42 5,317.12 5,089.86 Gross Profit 18,904.33 18,618.63 16,954.52 14,500.84 13,267.74 11,807.70 11,140.57 10,577.92 9,717.29 9,077.17 8,505.03 GP Margin 67.97% 67.59% 65.78% 63.73% 60.96% 61.63% 65.03% 64.65% 64.12% 63.06% 62.56% Total Expenditure 20,620.91 20,419.72 19,483.04 17,762.83 17,251.38 14,910.94 13,951.18 13,494.26 12,702.32 11,918.50 11,115.22 Power & Fuel Cost - 397.18 364.84 353.61 331.03 308.26 327.43 335.11 298.82 251.73 245.92 % Of Sales - 1.44% 1.42% 1.55% 1.52% 1.61% 1.91% 2.05% 1.97% 1.75% 1.81% Employee Cost - 4,832.83 4,310.04 3,830.08 3,529.91 3,251.83 3,027.01 2,856.53 2,690.10 2,633.82 2,434.01 % Of Sales - 17.54% 16.72% 16.83% 16.22% 16.97% 17.67% 17.46% 17.75% 18.30% 17.90% Manufacturing Exp. - 1,894.12 1,779.35 1,589.90 1,453.22 1,206.33 1,372.03 1,284.94 1,220.67 1,192.77 1,023.49 % Of Sales - 6.88% 6.90% 6.99% 6.68% 6.30% 8.01% 7.85% 8.05% 8.29% 7.53% General & Admin Exp. - 1,791.63 1,673.94 1,423.23 1,206.07 986.01 1,289.13 1,096.50 1,002.43 868.31 845.89 % Of Sales - 6.50% 6.49% 6.26% 5.54% 5.15% 7.52% 6.70% 6.61% 6.03% 6.22% Selling & Distn. Exp. - 1,834.86 1,724.97 1,694.30 1,670.00 1,298.62 1,252.04 1,281.29 1,082.90 1,009.21 818.76 % Of Sales - 6.66% 6.69% 7.45% 7.67% 6.78% 7.31% 7.83% 7.15% 7.01% 6.02% Miscellaneous Exp. - 740.11 810.33 619.43 565.55 508.00 692.12 855.40 968.98 645.54 818.76 % Of Sales - 2.69% 3.14% 2.72% 2.60% 2.65% 4.04% 5.23% 6.39% 4.48% 4.83% EBITDA 7,190.24 7,127.90 6,291.05 4,990.29 4,511.96 4,248.65 3,180.81 2,868.15 2,453.39 2,475.79 2,479.67 EBITDA Margin 25.85% 25.87% 24.41% 21.93% 20.73% 22.18% 18.57% 17.53% 16.19% 17.20% 18.24% Other Income 960.24 861.87 746.57 512.13 321.73 269.77 369.38 476.57 357.65 228.69 208.21 Interest 58.11 62.01 89.88 109.54 106.35 160.70 197.36 168.43 114.23 159.38 206.63 Depreciation 1,112.99 1,106.95 1,051.02 1,172.11 1,051.95 1,067.66 1,174.65 1,097.15 949.83 1,322.93 754.22 PBT 6,979.38 6,820.81 5,896.72 4,220.77 3,675.39 3,290.06 2,178.18 2,079.14 1,746.98 1,222.17 1,727.03 Tax 1,572.57 1,529.76 1,546.59 1,202.86 933.80 888.76 631.20 569.53 250.11 179.76 331.59 Tax Rate 22.53% 22.43% 27.12% 29.79% 26.73% 27.01% 28.98% 27.39% 14.98% 14.71% 19.20% PAT 5,406.81 5,294.37 4,123.14 2,804.51 2,529.57 2,417.66 1,593.98 1,544.87 1,413.31 1,013.38 1,372.01 PAT before Minority Interest 5,413.96 5,291.05 4,155.31 2,835.49 2,559.47 2,401.30 1,546.98 1,509.61 1,419.35 1,042.41 1,395.44 Minority Interest 7.15 3.32 -32.17 -30.98 -29.90 16.36 47.00 35.26 -6.04 -29.03 -23.43 PAT Margin 19.44% 19.22% 16.00% 12.33% 11.62% 12.62% 9.30% 9.44% 9.33% 7.04% 10.09% PAT Growth 24.72% 28.41% 47.02% 10.87% 4.63% 51.67% 3.18% 9.31% 39.46% -26.14% EPS 67.08 65.69 51.16 34.80 31.38 30.00 19.78 19.17 17.53 12.57 17.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 32,099.24 27,973.92 24,638.09 22,513.55 19,927.56 17,402.96 15,781.91 14,113.52 12,800.51 11,985.88 Share Capital 161.52 161.47 161.43 161.36 161.29 161.25 161.14 161.02 160.90 160.68 Total Reserves 31,886.02 27,768.42 24,437.55 22,315.35 19,730.58 17,207.54 15,578.07 13,898.74 12,580.21 11,735.79 Non-Current Liabilities 263.18 217.06 258.64 276.16 344.24 383.41 268.82 202.95 191.34 298.70 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.13 Long Term Provisions 109.12 94.24 81.73 81.63 95.97 105.14 108.12 124.45 125.61 132.00 Current Liabilities 3,183.42 2,862.25 2,699.74 2,632.37 2,691.94 2,619.29 2,368.08 2,731.70 2,555.83 2,954.47 Trade Payables 1,883.71 1,684.64 1,638.92 1,569.73 1,495.49 1,612.12 1,481.35 1,580.02 1,298.21 990.84 Other Current Liabilities 466.85 423.08 414.08 431.25 571.32 455.04 406.59 579.07 670.58 582.73 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 6.06 0.00 174.43 324.26 1,131.68 Short Term Provisions 832.86 754.53 646.74 631.39 625.13 546.07 480.14 398.18 262.78 249.22 Total Liabilities 35,545.84 31,053.23 27,596.47 25,422.08 22,963.74 20,405.66 18,418.81 17,048.17 15,547.68 15,239.05 Net Block 3,764.76 3,603.14 3,747.28 3,846.57 3,942.66 4,024.54 4,127.46 4,320.03 4,235.26 3,826.11 Gross Block 8,562.41 7,904.04 7,696.57 7,332.72 6,923.36 6,521.26 6,093.25 5,754.82 5,151.81 4,267.82 Accumulated Depreciation 4,794.26 4,261.00 3,872.09 3,471.43 2,969.11 2,477.73 1,963.56 1,434.79 916.55 441.71 Non Current Assets 17,137.07 16,146.43 14,225.34 14,015.14 12,772.99 11,378.60 8,940.16 9,110.00 9,202.34 8,771.68 Capital Work in Progress 638.40 670.27 504.25 267.68 355.11 319.73 297.33 462.60 555.77 550.72 Non Current Investment 10,501.68 9,410.17 9,137.91 8,934.88 7,844.78 6,481.76 3,865.46 3,597.56 3,648.03 3,716.59 Long Term Loans & Adv. 1,915.80 1,904.67 748.77 555.68 596.10 516.63 583.23 611.43 624.98 551.69 Other Non Current Assets 203.56 442.69 25.41 346.98 34.34 35.94 66.68 118.38 138.30 126.57 Current Assets 18,369.22 14,857.84 13,371.13 11,335.04 10,190.75 9,027.06 9,478.65 7,938.17 6,345.34 6,467.37 Current Investments 6,849.31 4,383.59 2,771.44 2,038.80 2,004.84 834.43 2,011.58 1,039.74 638.18 539.52 Inventories 3,607.12 3,254.28 3,277.36 3,485.81 3,085.81 3,021.36 2,868.41 3,037.98 2,653.50 2,918.47 Sundry Debtors 3,859.99 2,681.75 2,888.49 2,794.48 3,035.37 3,560.27 3,168.73 2,336.32 1,938.79 1,896.41 Cash & Bank 278.45 333.20 966.46 1,428.03 874.80 523.07 174.56 227.53 58.46 53.01 Other Current Assets 3,774.35 490.98 326.65 238.17 1,189.93 1,087.93 1,255.37 1,296.60 1,056.41 1,059.96 Short Term Loans & Adv. 3,349.91 3,714.04 3,140.73 1,349.75 897.44 826.45 992.56 958.47 774.66 725.25 Net Current Assets 15,185.80 11,995.59 10,671.39 8,702.67 7,498.81 6,407.77 7,110.57 5,206.47 3,789.51 3,512.90 Total Assets 35,506.29 31,004.27 27,596.47 25,350.18 22,963.74 20,405.66 18,418.81 17,048.17 15,547.68 15,239.05

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 31,193.45 26,706.43 23,407.78 20,841.69 18,326.53 15,763.00 15,012.28 14,229.19 12,543.66 11,516.22 Share Capital 161.52 161.47 161.43 161.36 161.29 161.25 161.14 161.02 160.90 160.68 Total Reserves 30,917.81 26,458.42 23,184.53 20,636.35 18,123.15 15,548.70 14,794.10 14,001.91 12,320.74 11,266.12 Non-Current Liabilities -31.04 81.92 183.53 621.70 1,660.47 2,972.37 4,646.15 4,259.05 4,514.99 1,407.13 Secured Loans 11.98 0.00 332.46 376.20 355.32 304.74 47.70 0.00 0.00 207.00 Unsecured Loans 0.00 0.00 -332.46 40.04 847.43 2,064.54 3,782.37 3,662.11 3,645.36 14.88 Long Term Provisions 148.69 129.26 102.16 100.22 116.17 133.27 121.41 137.92 140.52 144.68 Current Liabilities 5,483.96 5,245.77 5,033.27 4,912.87 4,591.14 4,393.14 3,771.51 3,832.22 3,388.91 7,776.05 Trade Payables 2,837.49 2,473.98 2,534.52 2,508.10 2,066.82 2,281.81 1,947.99 2,119.12 1,586.30 1,475.82 Other Current Liabilities 772.99 890.98 1,007.60 769.81 1,093.21 706.65 541.86 647.04 908.95 1,006.14 Short Term Borrowings 80.12 247.02 187.90 393.34 334.73 447.15 486.16 435.87 467.23 4,969.67 Short Term Provisions 1,793.36 1,633.79 1,303.25 1,241.62 1,096.38 957.53 795.50 630.19 426.43 324.42 Total Liabilities 36,742.17 32,130.02 28,930.34 26,651.95 24,837.20 23,422.79 23,761.91 22,672.90 20,885.79 21,049.49 Net Block 9,895.14 9,493.61 9,100.65 9,621.91 9,393.77 9,558.59 9,546.51 9,949.14 9,508.16 9,368.32 Gross Block 19,655.92 18,160.54 17,204.76 16,968.35 15,647.05 14,913.62 13,790.31 12,960.01 11,370.70 10,167.62 Accumulated Depreciation 9,707.76 8,573.36 7,994.72 7,310.84 6,216.82 5,309.30 4,233.78 3,010.87 1,609.71 799.30 Non Current Assets 13,453.65 12,688.61 11,731.79 11,924.75 11,656.17 11,716.61 11,335.28 11,858.80 12,082.23 12,208.26 Capital Work in Progress 1,566.27 1,152.72 1,093.30 766.18 968.89 824.53 676.18 981.33 1,682.98 2,060.87 Non Current Investment 639.54 642.21 572.52 355.63 545.43 578.80 490.20 157.66 137.36 176.35 Long Term Loans & Adv. 1,038.36 844.39 845.11 736.39 645.57 677.08 455.57 514.96 543.67 426.18 Other Non Current Assets 203.09 442.07 60.38 383.22 102.51 77.61 166.82 255.71 210.06 176.54 Current Assets 23,248.97 19,392.45 16,805.06 14,710.83 13,181.03 11,706.18 12,426.63 10,814.10 8,803.56 8,841.23 Current Investments 7,293.23 4,807.01 3,089.86 2,194.97 2,286.37 1,016.52 2,125.79 1,102.21 837.39 582.34 Inventories 5,642.11 5,237.95 5,156.43 5,350.24 4,669.18 4,377.60 3,964.83 4,044.70 3,519.72 3,808.05 Sundry Debtors 5,506.37 4,770.66 4,057.00 3,424.44 3,445.68 3,891.31 4,150.72 3,102.45 2,582.17 2,356.27 Cash & Bank 799.84 874.97 1,564.62 1,928.48 1,401.23 1,003.91 618.81 965.61 638.27 871.40 Other Current Assets 4,007.42 567.64 373.99 305.56 1,378.57 1,416.84 1,566.48 1,599.13 1,226.01 1,223.17 Short Term Loans & Adv. 3,481.42 3,134.22 2,563.16 1,507.14 1,031.03 974.82 1,150.95 1,118.93 807.84 780.03 Net Current Assets 17,765.01 14,146.68 11,771.79 9,797.96 8,589.89 7,313.04 8,655.12 6,981.88 5,414.65 1,065.18 Total Assets 36,702.62 32,081.06 28,536.85 26,635.58 24,837.20 23,422.79 23,761.91 22,672.90 20,885.79 21,049.49

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 3,300.99 3,726.77 3,035.05 2,773.43 3,460.31 2,018.14 1,468.05 1,116.53 2,207.39 1,728.40 PBT 6,174.16 5,432.14 3,685.17 3,905.08 3,350.66 2,964.31 2,492.83 1,911.40 1,186.94 1,743.97 Adjustment -285.65 -342.91 269.57 73.26 520.41 -35.73 187.60 315.64 778.60 473.89 Changes in Working Capital -1,229.16 -138.30 164.57 -270.88 541.19 -245.46 -761.00 -588.00 573.12 -98.83 Cash after chg. in Working capital 4,659.35 4,950.93 4,119.31 3,707.46 4,412.26 2,683.12 1,919.43 1,639.04 2,538.66 2,119.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1,358.36 -1,224.16 -1,084.26 -934.03 -951.95 -664.98 -451.38 -522.51 -331.27 -390.63 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2,308.53 -2,882.82 -2,757.95 -2,463.73 -3,360.45 -1,126.33 -1,147.05 -592.16 -1,191.25 -1,205.67 Net Fixed Assets -626.50 -373.49 -600.42 -321.93 -437.48 -450.41 -173.16 -509.84 -889.04 1,487.25 Net Investments -3,557.23 -1,884.41 -935.67 -1,124.06 -2,533.43 -1,439.15 -1,239.74 -351.09 -30.10 164.99 Others 1,875.20 -624.92 -1,221.86 -1,017.74 -389.54 763.23 265.85 268.77 -272.11 -2,857.91 Cash from Financing Activity -1,073.93 -708.83 -424.77 -426.72 -65.80 -693.89 -473.32 -350.96 -1,010.80 -547.00 Net Cash Inflow / Outflow -81.47 135.12 -147.67 -117.02 34.06 197.92 -152.32 173.41 5.34 -24.27 Opening Cash & Equivalents 164.52 29.48 177.29 294.72 261.54 64.47 217.45 44.60 39.76 64.34 Closing Cash & Equivalent 82.74 164.52 29.48 177.29 294.72 261.54 64.47 217.45 44.60 39.76

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 5,004.98 4,133.91 3,237.65 3,325.90 3,755.20 3,068.45 1,691.14 1,462.76 2,381.76 1,740.81 PBT 6,820.81 5,896.72 4,220.77 3,675.39 3,290.06 2,178.18 2,079.14 1,669.46 1,222.17 1,727.03 Adjustment 517.74 640.77 878.19 967.47 1,130.91 1,365.53 1,268.77 1,293.82 1,374.42 950.85 Changes in Working Capital -665.47 -806.10 -559.42 -177.46 371.66 372.99 -1,063.54 -778.48 235.44 -429.38 Cash after chg. in Working capital 6,673.08 5,731.39 4,539.54 4,465.40 4,792.63 3,916.70 2,284.37 2,184.80 2,832.03 2,248.50 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1,668.10 -1,597.48 -1,301.89 -1,139.50 -1,037.43 -848.25 -593.23 -722.04 -450.27 -507.69 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -3,691.14 -2,988.03 -2,388.51 -1,871.88 -2,387.18 104.04 -1,668.68 -854.01 -1,310.21 -4,522.63 Net Fixed Assets -626.50 -373.49 -600.42 -321.93 -437.48 -450.41 -173.16 -509.84 -889.04 1,487.25 Net Investments -3,557.23 -1,884.41 -935.67 -1,124.06 -2,533.43 -1,439.15 -1,239.74 -351.09 -30.10 164.99 Others 492.59 -730.13 -852.42 -425.89 583.73 1,993.60 -255.78 6.92 -391.07 -6,174.87 Cash from Financing Activity -1,292.79 -1,200.43 -958.29 -1,599.79 -1,239.51 -2,948.82 -348.72 -385.48 -1,325.68 3,104.06 Net Cash Inflow / Outflow 21.05 -54.55 -109.15 -145.77 128.51 223.67 -326.26 223.27 -254.13 322.24 Opening Cash & Equivalents 512.34 561.33 658.11 790.43 649.13 508.36 853.47 610.35 858.15 545.84 Closing Cash & Equivalent 542.65 512.34 561.33 658.11 790.43 742.38 508.36 853.46 610.35 858.15

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 396.82 345.95 304.76 278.59 246.66 215.43 195.35 174.63 158.37 148.08 ROA 15.49% 12.67% 8.08% 11.91% 9.43% 11.94% 10.65% 9.01% 6.33% 9.13% ROE 17.20% 14.14% 9.11% 13.61% 10.97% 14.00% 12.67% 10.96% 7.91% 12.77% ROCE 21.59% 18.88% 12.84% 18.05% 15.15% 18.08% 16.69% 14.03% 9.34% 14.79% Fixed Asset Turnover 2.42 2.24 2.00 2.29 1.81 2.15 2.20 2.10 2.33 2.37 Receivable days 59.84 58.15 68.88 65.28 98.93 90.59 77.02 68.17 63.78 59.47 Inventory Days 62.76 68.18 81.97 73.59 91.60 79.30 82.64 90.76 92.66 93.49 Payable days 158.92 155.96 162.93 117.14 184.38 169.73 61.41 61.28 49.32 48.80 Cash Conversion Cycle -36.32 -29.63 -12.09 21.73 6.16 0.16 98.25 97.65 107.11 104.16 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.03 0.10 Interest Cover 429.12 245.29 135.96 142.27 62.77 83.23 147.90 161.62 31.28 12.86

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 384.84 329.72 289.24 257.78 226.73 194.85 185.62 175.92 155.15 142.23 ROA 15.36% 13.59% 10.19% 9.94% 9.95% 6.56% 6.50% 6.52% 4.97% 7.28% ROE 18.34% 16.63% 12.85% 13.10% 14.13% 10.09% 10.37% 10.65% 8.72% 12.61% ROCE 23.64% 22.77% 18.19% 17.24% 17.85% 12.53% 11.94% 10.20% 8.28% 13.24% Fixed Asset Turnover 1.96 2.00 1.81 1.82 1.85 1.89 1.79 1.25 1.36 1.40 Receivable days 50.64 45.49 44.13 42.19 47.44 54.10 55.36 68.17 61.60 57.62 Inventory Days 53.61 53.56 61.98 61.53 58.49 56.12 61.13 90.71 91.41 100.43 Payable days 108.56 103.64 111.52 98.28 107.95 128.84 59.02 57.37 46.96 51.51 Cash Conversion Cycle -4.31 -4.58 -5.41 5.44 -2.02 -18.63 57.47 101.50 106.05 106.55 Total Debt/Equity 0.00 0.01 0.02 0.04 0.10 0.18 0.29 0.29 0.33 0.46 Interest Cover 111.00 64.44 37.87 33.85 21.47 12.04 13.34 15.61 8.67 9.36

Top Investors:

hdfc mutual fund-hdfc arbitrage fund

lici index plus flexi smart growth fund

sbi arbitrage opportunities fund

government pension fund global

dsp multicap fund

icici prudential nifty 50 index fund

nps trust a/c uti pension fund limited-scheme cent

parag parikh arbitrage fund

uti nifty india manufacturing index fund

axis nifty 50 etf

Annual Reports:

News Update:

Cipla’s arm recalling over 20,000 packs of Ibuterol Sulfate Inhalation Aerosol
28th Aug 2025, 14:18 PM

The company is recalling 20,352 packs of the inhalation drug due to Failed Stability Specifications
Read More
Cipla’s Bengaluru manufacturing facility classified as VAI by USFDA
5th Aug 2025, 10:30 AM

USFDA had conducted the inspection at said facility from May 26 to May 30, 2025
Read More
Cipla reports 10% rise in Q1 consolidated net profit
25th Jul 2025, 17:22 PM

The total consolidated income of the company increased by 5.28% at Rs 7,216.03 crore for Q1FY26
Read More
Cipla - Quarterly Results
25th Jul 2025, 13:19 PM

Read More
Cipla signs definitive agreements for investment in iCaltech Innovations
22nd Jul 2025, 09:20 AM

iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus, with a core focus on respiratory care
Read More

Cipla Ltd.

Pharmaceuticals & Drugs - Global

BSE: 500087 | NSE: CIPLA

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Cipla Ltd.

Pharmaceuticals & Drugs - Global

BSE: 500087 | NSE: CIPLA

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: